Goal Management for Biotech Companies
Give leadership a clear view of program progress across research, clinical, and regulatory — every week, without another functional review.
How biotech companies actually run
Biotech companies run on program milestones — measured in months and years, not sprints. Leaders need to see where research, clinical, regulatory, and G&A are advancing and where cross-functional dependencies are stuck. Weekly Win gives every function a lightweight rhythm that surfaces execution against program plans.
Where the week falls apart
The patterns we hear from biotech companies again and again.
Program status hides in functional silos
Research, clinical, and regulatory each report on their own — cross-functional dependencies fall between the cracks.
Dependencies stall quietly
A vendor delay in one function slows the program weeks before leadership sees the impact.
Program reviews cluster monthly
Milestones are only reviewed formally at monthly ops meetings — slips accumulate in between.
G&A work is invisible
Finance, HR, and IR work quietly supports program execution but rarely shows up in the operating rhythm.
How Weekly Win helps
A lightweight operating rhythm — not another tool to manage.
A weekly rhythm across every function
Research, clinical, regulatory, CMC, and G&A teams post wins, what's next, and blockers in under five minutes — tagged by program.
Leadership-ready roll-ups
A weekly digest surfaces program progress and cross-functional risk — no program review required to see it.
Dependency visibility
Cross-functional blockers surface early so program leaders can intervene before milestones slip.
Program-anchored goals
Wins connect to program milestones — IND, first-in-human, readouts — so weekly work is always anchored to the plan.
C-Suite Dashboard for Distributed Teams
A single centralized view of what was done, what stalled, execution themes, and key topics for the weekly leadership meeting.
What a week looks like
Examples of weekly wins in the language biotech companies use.
Completed the tox study readout for [Program]; results tracking to IND timeline.
Enrolled the first patient at Site 3 in the Phase 2 study.
Closed the pre-IND meeting request package with regulatory.
Resolved a CMC vendor delay that had threatened the batch schedule.
Built for every role on the team
CEOs & COOs
See every program's progress and cross-functional risk in one weekly digest.
Program Leaders
Track cross-functional execution without another functional review.
Function Heads
Show your function's work in the context of the programs it serves.
G&A Leaders
Make supporting work visible alongside program execution.
Frequently asked questions
Keep exploring
Bring a weekly rhythm to your biotech companie team
Join the early access list and be the first to try Weekly Win.